You are here » Home » Companies » Company Overview » Glaxosmithkline Pharma Ltd

Glaxosmithkline Pharma Ltd.

BSE: 500660 Sector: Health care
NSE: GLAXO ISIN Code: INE159A01016
BSE LIVE 15:40 | 27 May 3498.90 -3.35
(-0.10%)
OPEN

3468.45

HIGH

3603.00

LOW

3466.30

NSE LIVE 15:52 | 27 May 3528.35 22.65
(0.65%)
OPEN

3455.00

HIGH

3620.00

LOW

3436.20

OPEN 3468.45
PREVIOUS CLOSE 3502.25
VOLUME 713
52-Week high 3850.00
52-Week low 3035.65
P/E 77.03
Mkt Cap.(Rs cr) 29635.68
Buy Price 3550.00
Buy Qty 49.00
Sell Price 0.00
Sell Qty 0.00
OPEN 3468.45
CLOSE 3502.25
VOLUME 713
52-Week high 3850.00
52-Week low 3035.65
P/E 77.03
Mkt Cap.(Rs cr) 29635.68
Buy Price 3550.00
Buy Qty 49.00
Sell Price 0.00
Sell Qty 0.00

About Glaxosmithkline Pharma Ltd.

Glaxosmithkline Pharma Ltd

GlaxoSmithKline Pharma Ltd is one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. They also offer a range of v...> More

Glaxosmithkline Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   29,636
EPS - TTM () [*S] 45.42
P/E Ratio (X) [*S] 77.03
Face Value ()   10
Latest Dividend (%)   500.00
Latest Dividend Date 15 Jul 2016
Dividend Yield (%) 1.43
Book Value / Share () [*S] 240.97
P/B Ratio () [*S] 14.52
[*C] Consolidated     [*S] Standalone

Glaxosmithkline Pharma Ltd - Financial Results

Particulars ( cr) Mar 2016 Mar 2015 % Chg
Net Sales 692.97 618.06 12.12
Other Income 40.27 40.48 -0.52
Total Income 733.24 658.54 11.34
Total Expenses 564.06 498.1 13.24
Operating Profit 169.18 160.44 5.45
Net Profit 105.98 102.85 3.04
Equity Capital 84.7 84.7 -
> More on Glaxosmithkline Pharma Ltd Financials Results

Glaxosmithkline Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Aurobindo Pharma 763.95 2.65 44706.35
Cipla 473.65 1.29 38055.41
Cadila Health. 327.35 2.19 33510.82
Glaxosmit Pharma 3498.90 -0.10 29635.68
Divi's Lab. 1083.45 3.88 28760.18
Glenmark Pharma. 874.60 1.11 24681.21
Piramal Enterp. 1394.10 3.42 24055.19
> More on Glaxosmithkline Pharma Ltd Peer Group

Glaxosmithkline Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 75.00
Banks/FIs 8.03
FIIs 2.25
Insurance 0.00
Mutual Funds 1.67
Indian Public 11.99
Custodians 0.00
Other 1.05
> More on Glaxosmithkline Pharma Ltd Share Holding Pattern

Glaxosmithkline Pharma Ltd - Research Reports

Date Broker Action Price Report
02/11 Angel Broking Neutral 3295 PDF IconDetails
06/08 Angel Broking Neutral 3746 PDF IconDetails
13/08 Angel Broking Neutral 2513 PDF IconDetails
> More on Glaxosmithkline Pharma Ltd Research Reports

Glaxosmithkline Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 3.47% 4.05% 5.34% 5.25%
1 Month -6.86% -6.38% 2.26% 2.21%
3 Month 11.08% 12.15% 15.11% 16.03%
6 Month 6.86% 7.42% 2.68% 3.46%
1 Year 10.71% 11.39% -3.31% -2.14%
3 Year 53.27% 55.29% 33.06% 34.09%

Glaxosmithkline Pharma Ltd - STOCK STRENGTH

Today's Low/High 3466.30
3603.00
Week Low/High 3348.00
3603.00
Month Low/High 3339.00
3806.00
YEAR Low/High 3035.65
3850.00
All TIME Low/High 25.75
3850.00
Widgets Magazine
Widgets Magazine
Widgets Magazine

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard